Clinical Supply Logistic Articles

1. Post-Acquisition Clinical Supply Chain Risk: Continuity Before Consolidation 11/11/2026

   Acquisitions can disrupt clinical trial supply when knowledge, decision rights, inventory data, and supplier responsibilities fail to transfer. Learn how to protect continuity.

2. Where Comparator Decisions Are Written Down 11/10/2026

   Comparator sourcing decisions often happen separately from clinical oversight. Learn how EU and U.S. regulatory documentation can leave gaps between procurement and participant treatment.

3. Lessons From Ebola And Marburg: Building Clinical Trial Supply Chains Under Pressure 11/9/2026

   Lessons from Ebola and Marburg vaccine trials reveal how cold chain readiness, trained personnel, and contingency planning help maintain clinical supply under pressure.

4. Beyond The Checklist: Auditing Clinical Supply Export Compliance 11/4/2026

   Auditing clinical supply export compliance means testing shipment controls, restricted party screening, technology transfers, and partner oversight to prevent risks and delays.

5. Clinical Trial Supplies: A Fast-Growing Market Built On Logistics 11/2/2026

   Clinical trial supplies market growth is driving changes in logistics, forecasting, outsourcing, and distribution. Explore the operational decisions shaping clinical supply.

6. The Operational Challenge Of Concurrent Shelf Life Extensions 10/28/2026

   Concurrent shelf life extensions can complicate global clinical trial supply, creating different expiry dates, labeling requirements, inventory constraints and country activation risks.

7. Clinical Trial Supply Challenges In Alzheimer's Trials 10/27/2026

   Alzheimer’s trials challenge clinical supply teams with volatile enrollment, global distribution, cold chain needs, real-time forecasting and patient-centered planning.

8. Who Decides When The Comparator Changes? 10/22/2026

   Clinical trial comparator sourcing can affect patient treatment and study design. Learn when comparator changes become clinical decisions and who should own them.

9. Is Your Supply Chain Ready For The End Of Class VI? 10/21/2026

   Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.

10. Why Shelf Life Should Shape Global Country Activation 10/21/2026

    Shelf life can shape global country activation strategy, helping clinical supply teams reduce regulatory risk, resupply challenges, relabeling and enrollment delays.